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Endothelial cells enhance the in vivo bone-forming
ability of osteogenic cell sheets
Roge´rio P Pirraco1,2,3, Takanori Iwata1, Toshiyuki Yoshida1, Alexandra P Marques2,3, Masayuki Yamato1, Rui L Reis2,3
and Teruo Okano1
Addressing the problem of vascularization is of vital importance when engineering three-dimensional (3D) tissues.
Endothelial cells are increasingly used in tissue-engineered constructs to obtain prevascularization and to enhance in vivo
neovascularization. Rat bone marrow stromal cells were cultured in thermoresponsive dishes under osteogenic
conditions with human umbilical vein endothelial cells (HUVECs) to obtain homotypic or heterotypic cell sheets (CSs).
Cells were retrieved as sheets from the dishes after incubation at 20 1C. Monoculture osteogenic CSs were stacked on top
of homotypic or heterotypic CSs, and subcutaneously implanted in the dorsal flap of nude mice for 7 days. The implants
showed mineralized tissue formation under both conditions. Transplanted osteogenic cells were found at the new tissue
site, demonstrating CS bone-inductive effect. Perfused vessels, positive for human CD31, confirmed the contribution of
HUVECs for the neovascularization of coculture CS constructs. Furthermore, calcium quantification and expression of
osteocalcin and osterix genes were higher for the CS constructs, with HUVECs demonstrating the more robust osteogenic
potential of these constructs. This work demonstrates the potential of using endothelial cells, combined with osteogenic
CSs, to increase the in vivo vascularization of CS-based 3D constructs for bone tissue engineering purposes.
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The use of scaffolds in combination with osteogenic cells has
been the gold standard in bone tissue engineering strate-
gies.1,2 Engineered constructs are transplanted to patients to
restore or improve the functions of bone tissue. However,
such constructs have often failed to produce the desired
results because of issues such as the poor biocompatibility
and immunogenicity of the biomaterials used, and cell
necrosis at the bulk of the scaffold related to deficient oxygen
and nutrient diffusion.3–7 Oxygen and nutrient supply is a
critical issue when creating thick-engineered tissues such as
the bone.1,2 The consequence of this problem is that success-
ful production of tissue-engineered products is virtually
limited to thin tissues such as the skin.7 This scenario
illustrates how vascularization is a major hurdle of bone
tissue engineering. An approach that has been increasingly
studied to overcome this issue is the in vitro prevasculariza-
tion of the constructs.4,7–9 This strategy relies on combining
with the engineered construct, endothelial cells that will self-
organize in prevascular structures, and then anastomose with
the host vasculature after implantation. In fact, the success
of this approach to solve the vascularization issue of tissue-
engineered constructs strongly depends on a fast and
functional anastomosis of the prevascular network with the
host’s vasculature.7
CS engineering, as proposed by our group,10–12 is based on
the use of thermoresponsive poly(N-isopropylacrylamide)
(PIPPAam)-grafted culture surfaces that allow the recovery of
confluent cells in the form of sheets. The principle of the
method is based on the hydrophilic/hydrophobic nature of
PIPPAam, below/above its low critical solution temperature,
respectively, forming cell-adhesive and -repellent10–12 surfaces.
Cell adhesion is therefore controllable by modulating the
temperature. Using this strategy, our group has been propos-
ing solutions for the regeneration of cornea,10 myocardium,13
periodontal ligament14 and bladder,15 among others. Recently,
we proposed the use of osteogenic CSs produced using
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thermoresponsive dishes for bone tissue engineering applica-
tions.16 In that study, using a single CS, we successfully obtained
ectopic formation of vascularized bone with marrow.
Osteogenic CSs obtained by mechanical retrieval with cell
scrapers, alone or combined with scaffolds, were also tested
for bone tissue engineering purposes, but the general outcome
was an insufficient quantity of new bone tissue formed.17–19
However, Nakamura et al20 demonstrated the full regenera-
tion of a rat critical size defect by using CSs recovered by a
cell scraper. These studies show how scaffold-free, CS-based
constructs can be applied for bone regeneration.
The recovery of CSs using thermoresponsive methods
presents several advantages over the use of enzymatic and
mechanical dissociation methods. It has been demonstrated
that mechanical recovery of cells by scraping depletes ECM
proteins from the resulting sheets.21 On the contrary,
recovery of cells from thermoresponsive dishes preserves
extracellular matrix proteins,11,12 which act as a natural glue,
thus avoiding the use of sutures after transplantation.11,12
This advantage has also been explored to build three-
dimensional (3D) CS-based tissues, as the adhesion of the
successive CSs occurs naturally. The vascularization of the 3D
CS-based tissues is an essential issue as necrosis affects non-
vascularized-transplanted tissues thicker than 100 mm.22 This
was previously addressed by Shimizu and co-workers22 by
multitransplanting rat cardiomyocyte CSs. Using this strategy,
the authors were able to create 1-mm-thick myocardium with
an organized vascular network. The prevascularization of
CS-based 3D constructs has nevertheless been the focus of
recent works.23–25 The combination of several myoblasts
sheets, recovered from PIPPAam dishes, and human umbi-
lical vein endothelial cells (HUVECs) using a CS stacking
methodology resulted in the generation of a prevascularized
cell-dense tissue.24 This work is a proof-of-concept on how
CS engineering has the potential to produce 3D prevascu-
larized tissues.
Considering the need to promote the formation of vas-
cularized neobone tissue, the aim of the present work was to
further improve our previously proposed CS-based strategy
for bone tissue engineering. With this purpose, the potential
of combining osteogenic CSs with endothelial cells to
increase the vascularization of cell constructs was assessed,
and the influence of endothelial cells over the amount of bone
tissue formed was demonstrated. Rat osteogenic CSs were
obtained using thermoresponsive dishes and were stacked
with HUVECs cultured in between. The constructs were then
implanted subcutaneously in the dorsal flap of nude mice and
characterized in terms of involvement of the transplanted cells
on both bone tissue formation and vascularization.
MATERIALS AND METHODS
Thermoresponsive Culture Surfaces
Thermoresponsive dishes (CellSeed, Tokyo, Japan) were pre-
pared as described previously.26 Briefly, N-isopropylacry-
lamide monomer in 2-propanol solution was spread onto
35-mm-diameter culture dishes (BD Biosciences, Franklin
Lakes, NJ, USA). Dishes were then irradiated by electron
beam, resulting in both polymerization and covalent grafting
of PIPAAm onto the cell culture surfaces. PIPAAm-grafted
dishes were rinsed with cold-distilled water to remove
ungrafted monomer, and dried in nitrogen gas. Dishes were
finally sterilized with ethylene oxide gas before experimental
use.
Cell Sheet Fabrication
Bone marrow was flushed from the femurs of 4-week-old
male wistar rats (Charles River, Yokohama, Japan). After
careful pipetting to disaggregate any clumps, the suspension
was seeded in 75 cm2 Primaria culture flasks (BD Bios-
ciences) and cultured in basal medium (a-minimum essential
medium with glutamax I, low glucose; Gibco-BRL Life-
Technologies, Grand Island, NY, USA), supplemented with
10% fetal bovine serum (Japan Bioserum, Japan) and 100U/ml
of penicillin–streptomycin (Sigma-Aldrich, Tokyo, Japan), at
37 1C in a 5% CO2 humidified atmosphere. After 24 h of
culture, non-adherent cells were removed and the adherent
cells were then maintained in culture until semiconfluence
was achieved. Cell sheets (CSs) were fabricated and stacked
as depicted in Figure 1. Rat bone marrow stromal cells
(rBMSCs) were detached using a 0.25% trypsin-EDTA
solution (Gibco-BRL LifeTechnologies) and seeded in
35-mm-diameter thermoresponsive dishes at a concentration
of 2.5 105 cells per dish. Cultures were maintained for 21
days in osteogenic medium (basal medium supplemented
with 10 8M dexamethasone (Dexart; Fuji Pharma, Tokyo,
Japan), 50 mg/ml L-ascorbic acid phosphate (Wako Pure
Chemicals, Osaka, Japan), and 10mM b-glycerophosphate
(Sigma-Aldrich). HUVECs were purchased from Lonza
(Lonza, Japan), seeded in 75 cm2 Primaria culture flasks, and
cultured in endothelial cell growth medium MV2 (ECGM;
Promocell, Germany).
Establishment of Cocultures
HUVECs at passage 3 were seeded on the thermoresponsive
dishes with the rBMSCs, at a density of 1 105 cells per dish,
4 days before the rBMSCs completed the 21 days of osteo-
genic differentiation. Cocultures were maintained in ECGM
supplemented with 10 8M dexamethasone, 50 mg/ml
L-ascorbic acid phosphate (Wako), and 10mM b-glycero-
phosphate (Sigma-Aldrich) for 3 days until transplantation.
Recovery of Cells from Thermoresponsive Dishes
To recover the cells from the thermoresponsive dishes, cul-
ture medium was removed from the culture dishes and
replaced by 1ml of PBS (Sigma-Aldrich). A poly(vinylidene
difluoride) membrane (Immobilon-P; Millipore Corpora-
tion, Billerica, MA, USA) with a diameter of 2 cm was placed
over the rBMSC monocultures and incubated at 20 1C for
10min. After this time, CSs spontaneously detached from
thermoresponsive dishes. CS membrane constructs were
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stacked over the rBMSC/HUVEC cocultures and the proce-
dure to detach the adhered CSs was repeated. Controls
consisted of two stacked monocultured osteogenic CS.
Subcutaneous Transplantation
Subcutaneous transplantation of the stacked CSs was carried
out as reported previously.27 Briefly, 6-week-old female nude
mice (Charles River) were anesthetized with a constant flux
of 4% of isofluorane. Dorsal skin was cut open using
3 3 cm2 cutting sides. Recovered CS constructs were placed
on mouse subcutaneous dorsal flap and left to adhere to the
connective tissue of dorsal skin for 5min. After that time, the
poly(vinylidene difluoride) membranes were removed and
silicone membranes were placed over the CSs to prevent the
contact between the CS and the muscular tissue. Control
mice were prepared by implanting constructs composed of
two stacked osteogenic monocultured sheets. Skin incisions
were closed using 5-0 nylon sutures. Five animals per
condition, experimental and controls, were subjected to the
transplantation procedure. Animals were kept with food and
water ad libitum for all the experiment duration. After 7 days
of transplantation, animals were killed with CO2 and
implants were recovered for histological characterization.
Histological Characterization
Both in vitro recovered CS constructs and implanted samples
were fixed in 4% paraformaldehyde (Wako Pure Chemicals)
and embedded in paraffin, without demineralization to
obtain 5-mm-thick sections. Hematoxylin and eosin (H&E)
staining was performed following standard protocols.
Immunostaining was performed in both in vitro recovered CS
constructs and implanted samples using the following anti-
bodies: goat anti-mouse/-rat SRY (Santa Cruz Biotechnology,
Santa Cruz, CA, USA; Yannaki et al28), rabbit anti-human/-
mouse/-rat collagen I (Abcam, Cambridge, MA, USA; Husse
et al29), rabbit anti-human/-rat/-mouse osteopontin (Abcam;
Chiba et al30), rabbit anti-human/-mouse/-rat osterix
(Santa Cruz Biotechnology; Strecker et al31) and mouse
anti-human CD31 (DakoCytomation, Glostrup, Denmark;
Moriyama et al32). Briefly, sections were incubated with
the primary antibody overnight at 4 1C and then for 1 h
at room temperature, with the biotinylated secondary
antibody (DakoCytomation). Control samples were sub-
jected to incubation only with the secondary antibody eg, see
Supplementary Figure 1. Sections were incubated with
streptavidin-HRP (DakoCytomation) solution for 20min
and then treated with DAB chromogenic substrate solution
(DakoCytomation). Stained sections were analyzed with an
Eclipse E800 microscope (Nikon, Tokyo, Japan). To assess the
mineral deposition, alizarin red staining was performed both
on the dishes with the differentiated rBMSCs and on the
deparaffinized histological sections. Samples were incubated
with alizarin red S solution (Sigma-Aldrich) and observed in
the microscope until correct amount of color developed.
Cells were then counterstained with hematoxylin and washed
in ethanol and xylene.
Quantitative RT-PCR Analysis
RNA extraction and cDNA production
mRNA was extracted from tissues using Trizol (Invitrogen,
Carlsbad, CA, USA) reagent according to the manufacturer’s
instructions. Briefly, 800 ml of Trizol was added per 50mg of
Figure 1 Subcutaneous transplantation of rat bone marrow stromal cell (rBMSCs) osteogenic cell sheets cocultured with human umbilical vein
endothelial cells (HUVECs). rBMSCs were isolated from rat’s femurs, expanded, and seeded in thermoresponsive dishes. After 17 days of culture in
osteogenic medium, HUVECs were seeded on top of the confluent rBMSCs. Both cells were cocultured for further 4 days. CSs were retrieved from the
dishes by low temperature treatment. Monocultured CSs were stacked on top of cocultured CSs and implanted on the dorsal flap of nude mice. A
silicon membrane was used to cover the CSs and the flap was closed and sutured.
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the tissue and samples were homogenized by vigorous
pipetting and maceration. Following 5min incubation, 160 ml
of chloroform (Sigma, USA) was added to each sample;
samples were then incubated for 15min at 4 1C and centri-
fuged at 13 000 r.p.m. for 15min at 4 1C. After the centri-
fugation, the aqueous part of each sample was collected and
an equal volume of isopropanol (Sigma) was added.
Following an overnight incubation at  20 1C, samples were
centrifuged at 9000 r.p.m. for 10min at 4 1C. Supernatants
were discarded and pellets were washed in ethanol, cen-
trifuged at 9000 r.p.m. for 5min at 4 1C, and resuspended in
12 ml of RNase/DNase free water (Gibco, Paisley, UK). RNA
quantity and purity were assessed with a NanoDrop ND-1000
spectrophotometer (NanoDrop Technologies, Wilmington,
DE, USA). Samples with a 260/280 ratio between 1.6 and 2.0
were used for cDNA synthesis. The cDNA synthesis was
performed using iScript cDNA synthesis kit (Bio-Rad, USA)
and the MiniOpticon Real-Time PCR Detection System (Bio-
Rad). An initial amount of 2mg of mRNA was used in a total
volume of 20 ml of RNase/DNase free water.
Quantitative real-time PCR
Mouse OCN (osteocalcin), COL1a1 (collagen I), and OSX
(osterix) transcripts were quantified in the cDNA samples
using a quantitative real-time PCR reaction. For each sample,
GAPDH was used as the housekeeping gene. The primers
were designed using the Primer 3 software (v. 0.4.0), inserted
in PrimerBLAST to check for specificity, and synthesized
by MWG Biotech (Germany) as follows: OCN forward, 50-CT
GAGTCTGACAAAGCCTTC-30 and OCN reverse, 50-GCTG
TGACATCCATACTTGC-30; COL1A1 forward, 50-GAGCGG
AGAGTACTGGATCG-30 and COL1A1 reverse, 50-GCTTCT
TTTCCTTGGGGTTC-30; OSX forward, 50-GCTCCTCGGTT
CTCTCCATCTG-30 and OSX reverse, 50-TGTGTTGCCTGG
ACCTGGTG-30; mouse GAPDH forward, 50-ACGGCCGC
ATCTTCTTGTGCA-30 and mouse GAPDH reverse, 50-AAT
GGCAGCCCTGGTGACCA-30. A concentration of 200 nM
was used for all the primers in a final volume of 25ml of
sample. The real-time PCR reaction was carried out using the
EvaGreen SuperMix (Bio-Rad) following the manufacturer’s
instructions in a MiniOpticon Real-Time PCR Detection
System (Bio-Rad). The relative quantification of the referred
gene transcripts expression was performed using the 2DDCT
method (Perkin-Elmer User Bulletin No. 2). All values were
first normalized against GAPDH values and then the CSs with
HUVEC values against the CS-alone values.
Calcium Quantification
Halves of the recovered implants were weighted and incu-
bated in 0.5M HCl to remove and dissolve the calcium.
Calcium quantification in the obtained solutions was per-
formed with the o-cresolphtalein-complexon method using
the Roche Cobas kit (Roche Diagnostics, Germany) following
the manufacturer’s instructions. The absorbance of the samples
was read at 570 nm in a microplate reader Synergy-HT
(Bio-Tek, Hamburg, Germany). The calcium concentrations
were extrapolated from the calibration curve obtained using
serial dilutions of a calcium chloride solution and then
normalized with the initial tissue mass. The results for the
animals belonging to each transplantation group (CS with
HUVECs and CS alone) were averaged and analyzed.
Statistical Analysis
The results of the quantitative real-time PCR and calcium
quantification were subjected to statistical analysis. Values for
the animals of each group were averaged and analyzed using
the Student’s t-test. Results were considered significant for
Po0.05.
RESULTS
In vitro CS Characterization
Osteogenic differentiation of rBMSCs in the thermo-
responsive dishes was confirmed by the intense and uniform
alizarin red staining for calcium deposition, observed in the
culture in the osteogenic medium (Figure 2a, left dish) in
contrast with the absence of staining detected in the basal
medium culture (Figure 2a, right dish). The presence of
HUVECs in coculture with the rBMSCs was assessed by
immunohistochemistry against human CD31 (Figures 2c and d).
HUVECs seeded on the rBMSCs cultured under osteogenic
conditions, after 3 days, were organized in round or elon-
gated colonies on top of the rBMSCs. After recovery from the
thermoresponsive dishes following low temperature treat-
ment, the organization of the HUVECs remained intact as
observed after immunostaining for human CD31 in a
transversal section of the cocultured CSs (Figure 3a).
After recovery from dishes following low temperature
treatment, homotypic and heterotypic CSs were character-
ized by histology. H&E staining revealed that the CSs were
composed of a thick collagenous matrix (Figure 3b). Alizarin
red staining (Figure 3c) confirmed matrix mineralization in
the sheets. The osteogenic character of the CSs was further
corroborated by the positive immunostaining for the matrix
protein osteopontin (Figure 3d) and for the transcription
factor osterix (Figure 3e). The male origin of the cells
forming the sheets was also confirmed by the positivity for
SRY marker (Figure 3f).
Implants’ Characterization
The characterization of the implanted coculture and control
constructs was performed 7 days after implantation. The
formation of the new tissue was assessed by H&E staining
(representative images in Figures 4a and b). The new tissue
developed in patches along the dorsal flap of the mice; the
patches are apparently larger in the cocultured (Figure 4a)
than in the control (Figure 4b) conditions. The same trend
was visible when comparing the different mice transplanted
with the different types of CSs indicating the reproducibility
of our procedures. The deposition and mineralization of an
osteogenic matrix was confirmed by the presence of the bone
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protein osteopontin (Figures 4c and d) surrounding the
mineralized tissue, as determined by alizarin red staining
(Figures 4e and f). Comparing the SRY and the osterix
stainings that, respectively, identify only rat male cells
(Figures 5a and b) and both mouse and rat cells (Figures 5c
and d), it was possible to conclude that osteogenic cells both
from the transplanted CSs and from the host are present and
contribute to the formation of mineralized tissue. Further-
more, transcripts of bone-related genes were quantified for
the retrieved implants (Figure 5e). OCN and OSX were sig-
nificantly upregulated, respectively, 19.6 and 8.7 times after
the implantation of the cocultured constructs and in relation
to the construct without HUVECs. No statistical significant
difference was detected for the COL1a1 transcripts quantity
between coculture constructs and controls.
The amount of calcified tissue that was produced after the
transplantation of the cocultured and control constructs was
determined through calcium quantification (Figure 5f). The
calcium values per amount of retrieved tissue detected for the
coculture constructs were significantly higher than for the
controls.
The presence of human endothelial cells in the retrieved
cocultured implants was confirmed by immunostaining for
human CD31 (Figure 6). Chimeric perfused vessels, formed
by endothelial cells positive for human CD31, and host
endothelial cells, negative for that marker, were identified in
all the animals transplanted with the CSs cocultured with
HUVECs.
DISCUSSION
Recently, we reported the development of osteogenic CSs
using thermoresponsive dishes.16 A single osteogenic CS was
able to induce the formation of vascularized new bone tissue,
with marrow, after 6 weeks of implantation in nude mice.
Figure 2 Alizarin red staining (a) and human CD31 immunostaining (c, d) of osteogenic cell sheets cocultured with human umbilical vein endothelial
cells (HUVECs) just before retrieval from thermoresponsive dishes. Rat bone marrow stromal cells (rBMSCs) after 21 days of osteogenic differentiation
(a, left side dish) and cultured in basal medium (a, right side dish). The nuclei of all cells are stained blue with 4’,6-diamidino-2-phenylindole (DAPI)
nuclear staining (b) and HUVECs (human CD31-positive) distribution is depicted in green. A merge micrograph of (b) and (c) is presented in (d).
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Although it might not be sufficiently robust, the use of
osteogenic CSs represents a valuable approach not only for
bone replacement but also for bone regeneration.16,17,20 In
this sense, we intended to move forward to the creation of a
CS-based 3D construct and speculated that adding endo-
thelial cells within the stacked osteogenic CSs would increase
the amount of new tissue formed by promoting in vivo
vascularization of the construct.
Monocultured and cocultured with HUVECs, rat osteo-
genic CSs were produced using thermoresponsive surfaces
and the CS technology. As previously reported,16 mineralized
CSs, positive for matrix protein osteopontin and for bone-
related transcription factor osterix, all strong indicators of its
osteogenic nature, and composed of a thick collagenous
matrix, were obtained by culturing rBMSCs in osteogenic
conditions for 21 days.
The perfusion of tissue engineered constructs after trans-
plantation is one of the most critical aspects of a successful
regenerative approach.4,7–9 Strategies for improving the
vascularization of tissue engineered constructs consist on
the use of growth factors or on the constructs in vitro or
in vivo prevascularization.7,33 The use of angiogenic growth
factors is proven to increase the vascularization of implanted
constructs, but the difficulty in controlling their delivery
often results in disorganized and leaky vessels.7,33 In the case
of in vivo prevascularization, the need to perform multiple
surgeries is a serious drawback of the approach.7 For these
reasons, most of the current research is focusing on ways to
prevascularize constructs in vitro, using endothelial cells to
accelerate its perfusion after transplantation.4,7–9 The
potential of this strategy was demonstrated recently in a
work by Takebe and co-workers.34 In that work, researchers
used HUVECs and mesenchymal stem cells in coculture with
hepatocytes derived from induced pluripotent stem cells, to
recapitulate liver organogenesis and create an instructive
niche for hepatic cells. The result was the creation in vitro of
3D prevascularized liver buds, the vessels of which were
shown to connect rapidly with host vessels after implantation
and to be functional in vivo. Similar efforts have been intense
in the CS engineering field.23,24,35 Sasagawa et al24 seeded
HUVECs between myoblast CSs, building five-layer
constructs, to obtain in vitro a capillary-like network that
anastomosed when implanted in nude rats, allowing the
survival of the construct. Another work23 showed that the
positioning of endothelial cells within two fibroblast CS
constructs was determinant for tubular formation and
influences its lumen area in vitro. Thus, it is increasingly
clear that stacking several CS results in a suitable 3D
environment for endothelial cells to form a prevascular
network in vitro. In the herein presented work, it was shown
that HUVECs, seeded over rBMSCs 4 days before the end of
the osteogenic differentiation period, self-organized either in
small round colonies or in elongated aggregates resembling a
network. As these cocultured CSs were not cultured in vitro
after stacking with a second osteogenic CSs, which could
provide a 3D matrix for HUVECs reorganization, the
Figure 3 Histological characterization of osteogenic cell sheets after retrieval from thermoresponsive dishes. Cell sheets were stained with hematoxylin
and eosin (H&E) (b) and alizarin red (c) and immunostained for human CD31 (a) osteopontin (d), osterix (e), and SRY (f). Asterisks (*) indicate basal side
of the cell sheets.
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Figure 4 Histological characterization of retrieved implants 7 days after transplantation of the coculture (a, c, e) or monoculture (b, d, f) constructs.
Retrieved constructs were stained with hematoxylin and eosin (H&E) (a, b) and alizarin red (e, f) and immunostained for osteopontin (c, d).
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formation of capillary-like structures, as seen in other
works,23,24,35 was not expected.
The transplantation of stacked CS constructs to nude mice
resulted in mineralized tissue formation after 7 days, both in
the presence and absence of HUVECs. The new tissue was
strongly positive for alizarin red and for the bone matrix
protein osteopontin, which confirmed its osteogenic nature.
Moreover, it was organized in patches throughout the flap, in
Figure 5 Immunohistological characterization of retrieved implants after implantation of the cocultured CS (a, c) or monoculture CS (b, d) constructs.
Retrieved constructs were immunostained for SRY (a, b) and osterix (c, d). Quantitative RT-PCR analysis (e) and calcium quantification (f) were
performed in retrieved constructs, 1 week after implantation. In (e), osteocalcin (OC), osterix (Osx) and collagen I (Col I) transcripts were quantified in
both the cocultured CS and control cell sheet constructs (*Po0.05 relating to control values). Calcium was quantified using the o-cresolphtalein-
complexon method and values were normalized with tissue mass (*Po0.05 relating to coculture cell sheets).
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accordance to what was observed at later time points of
implantation of a single CS.16
The capacity of an implanted construct to induce the host
to produce new tissue is critical in a tissue engineering
strategy. The contribution to new tissue formation by the
transplanted cells was discriminated from the contribution by
host’s cells by immunostaining for SRY. The SRY protein is
encoded by a gene located in the short arm of the Y chro-
mosome36 and therefore can be used to identify cells from
male origin and, in this case, to distinguish transplanted cells
from cells from the host female mice. Therefore, the com-
parison of the SRY and osterix staining, the latter identifying
both mouse and rat cells, permitted to verify the presence of
host’s osteogenic cells in addition to the transplanted ones,
within the new formed tissue. This proves that the implanted
CS constructs are inducing new bone formation through the
recruitment of host’s bone-forming cells.
Although in vitro prevascularization ensures a faster per-
fusion of the construct after implantation, one of its pitfalls
comprehends the complex and slow determination of the
ideal in vitro culture conditions and construct 3D design that
allow endothelial cells to form networks, while maintaining
at the same time the function of tissue-specific cells.4,7 As CSs
are easy to obtain and to manipulate to assemble 3D
constructs, therefore allowing a fast optimization of protocols
for prevascularization, they present advantages. Furthermore,
in the present work, we intended to take advantage of the
mutual beneficial effects of the crosstalk between endothelial
cells and osteoblasts,4 and of the intimate relation between
blood vessels and bone formation4,37 to prove that the mere
presence of HUVECs within the CS-based construct would be
advantageous for new tissue formation. For this reason, the
CSs were only stacked right before implantation, alternatively
to the pre in vitro culture of the 3D constructs. To verify this,
we screened for the presence of HUVECs in new vessels, and
quantified the mineralized tissue formed after implantation
of HUVEC-containing CS-based constructs. In fact, the
transplanted human endothelial cells were distributed in
the new tissue, forming vessels that were perfused with
erythrocytes, thus showing HUVECs’ contribution to new
tissue vascularization. Furthermore, calcium quantification
permitted to conclude that a higher amount of mineralized
tissue was formed in the coculture constructs. Based on these
results, we are able to confirm that the HUVECs positively
contributed to the osteogenic potential of the developed 3D
CS-based constructs. This conclusion was further reinforced
by quantitative RT-PCR analysis of the transcripts of the
bone related genes OCN, OSX and COL1a1. After 21 days of
in vitro culture in the osteogenic medium, it was expected
that the totality of rBMSCs would be expressing those
markers. Therefore, we wanted to verify if that expression was
enhanced after coculture with HUVECs to correlate that with
the amount of bone-like tissue formed. The expression of
OCN and OSX was significantly increased for cocultured CS
implants, which is also consistent with the higher amount of
mineralized tissue formed. The similarity between conditions
in the COL1a1 transcript quantification can be explained by
the fact that this gene is also expressed in tissues other than
bone, such as the connective tissue found in the analyzed
dorsal flaps.38,39
Although it was demonstrated that the transplanted
HUVECs participate in the neovascularization of the con-
struct, we might speculate that in addition to a faster per-
fusion of the implant, the osteogenic effect of the endothelial
Figure 6 Immunohistological characterization of retrieved implants after implantation of the cocultured cell sheet constructs. Implants were
immunostained for human CD31 (a, b) and counterstained with 4’,6-diamidino-2-phenylindole (DAPI) (b). White arrows indicate perfused blood vessel.
ECs enhance osteogenic cell sheet’s potential
RP Pirraco et al
www.laboratoryinvestigation.org | Laboratory Investigation | Volume 00 00 2014 9
cells4,37 also led to a higher amount of bone tissue formed.
Future studies will clarify on the exact role of endothelial cells
on the formation of the new mineralized tissue.
Here we demonstrate that when combined with osteogenic
CS, endothelial cells participate in the neovascularization of
the new tissue formed in an ectopic implantation model. More
importantly, double osteogenic CS constructs, with endothelial
cells in between, led to a faster and more robust formation of
bone tissue, when compared with control constructs without
HUVECs. This, together with the presence of HUVECs in
new vessels, confirmed the positive contribution of these
endothelial cells to the osteogenic potential of the developed
3D CS-based constructs. It was also demonstrated that the
transplanted CS-based constructs induce bone formation
through the recruitment of host’s bone-forming cells. This
work highlights the versatility of CS engineering for tissue
engineering applications, in particular for bone tissue.
Supplementary Information accompanies the paper on the Laboratory
Investigation website (http://www.laboratoryinvestigation.org)
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